Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12726
CALL
NeuroOne Medical Technologies
NMTC
$17.7M
| $33.7K | ﹤0.01% |
+6,800
| New | +$33.9K |
|
12727
PUT
Rigel Pharmaceuticals
RIGL
$795M
| $33.6K | ﹤0.01% |
2,000
-4,320
| -68% | -$82.9K |
|
12728
CALL
Bar Harbor Bankshares
BHB
$681M
| $33.6K | ﹤0.01% |
+1,100
| New | +$36.4K |
|
12729
PUT
Hayward Holdings
HAYW
$3.22B
| $33.6K | ﹤0.01% |
2,200
+2,000
| +1,000% | +$31.3K |
|
12730
CALL
T-Rex 2X Inverse Tesla Daily Target ETF
TSLZ
$28M
| $33.6K | ﹤0.01% |
675
-640
| -49% | -$85.7K |
|
|
CHMI
12731
PUT
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $33.5K | ﹤0.01% |
12,700
-5,600
| -31% | -$16.8K |
|
12732
CALL
First Watch Restaurant Group
FWRG
$785M
| $33.5K | ﹤0.01% |
+1,800
| New | +$31.8K |
|
12733
PUT
iShares Russell 3000 ETF
IWV
$20.5B
| $33.4K | ﹤0.01% |
+100
| New | +$33.7K |
|
12734
CALL
Tiptree Inc
TIPT
$672M
| $33.4K | ﹤0.01% |
1,600
-27,300
| -94% | -$571K |
|
|
CYPH
12735
CALL
Cypherpunk Technologies Inc
CYPH
$69.4M
| $33.4K | ﹤0.01% |
11,600
+3,100
| +36% | +$9.21K |
|
12736
CALL
Sagimet Biosciences
SGMT
$656M
| $33.3K | ﹤0.01% |
7,400
+7,300
| +7,300% | +$37K |
|
12737
CALL
Mine Safety
MSA
$7.3B
| $33.2K | ﹤0.01% |
200
-60,700
| -100% | -$10.4M |
|
|
GOGL
12738
CALL
DELISTED
Golden Ocean Group
GOGL
| $33.2K | ﹤0.01% |
3,700
-7,900
| -68% | -$85.1K |
|
12739
PUT
BARK
BARK
$91.4M
| $33.1K | ﹤0.01% |
900
-845
| -48% | -$29.6K |
|
12740
CALL
Stoke Therapeutics
STOK
$2.02B
| $33.1K | ﹤0.01% |
3,000
-3,600
| -55% | -$44.2K |
|
|
MOGU
12741
MOGU Inc
MOGU
| $33.1K | ﹤0.01% |
15,235
-2,169
| -12% | -$4.7K |
|
12742
PUT
Full House Resorts
FLL
$81.7M
| $33K | ﹤0.01% |
8,100
+7,100
| +710% | +$33.5K |
|
12743
CALL
VistaGen Therapeutics
VTGN
$11.9M
| $33K | ﹤0.01% |
11,200
-2,800
| -20% | -$7.88K |
|
12744
CALL
ALPS Medical Breakthroughs ETF
SBIO
$215M
| $33K | ﹤0.01% |
+1,000
| New | +$37.7K |
|
12745
CALL
Baytex Energy
BTE
$3.06B
| $33K | ﹤0.01% |
12,800
+12,400
| +3,100% | +$35.2K |
|
12746
CALL
iRadimed
IRMD
$1.11B
| $33K | ﹤0.01% |
+600
| New | +$31.6K |
|
12747
SAP
SAP
$240B
| $33K | ﹤0.01% |
134
-65,871
| -100% | -$15.7M |
|
|
ENZ
12748
DELISTED
Enzo Biochem, Inc.
ENZ
| $32.8K | ﹤0.01% |
45,956
+19,362
| +73% | +$20.1K |
|
|
LFT
12749
Lument Finance Trust
LFT
$34.6M
| $32.8K | ﹤0.01% |
12,713
-2,155
| -14% | -$5.52K |
|
|
NIU
12750
CALL
Niu Technologies
NIU
$163M
| $32.8K | ﹤0.01% |
18,300
+16,700
| +1,044% | +$35.9K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.